Citron Research exposes Exact Sciences and PROVES beyond ANY doubt why this stock will soon be cut in half – so says a new reprot from Citron Research – Citron founder Andrew Left battled the CEO of Exact on CNBC on that topic for CNBC pro sub subscribers you can find that video here UPDATE: 10:15AM EST May 16th 2017 – Exas CEO issued the following statement in response to Citron. “Exact Sciences remains extremely confident in the near and long-term growth of Cologuard. We look forward to speaking with our valued investors both at the Bank of America Merrill…
This content is exclusively for paying members of Hedge Fund Alpha
Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha
Don’t have an account?
Subscribe now and get 7 days free!
